| Definium Therapeutics, Inc. | 7,334 | US$345K | 3.0% |
| Mbx Biosciences, Inc. | 5,500 | US$304K | 2.6% |
| Alumis Inc. | 8,497 | US$239K | 2.1% |
| Ataibeckley Inc. | 45,092 | US$238K | 2.1% |
| Trevi Therapeutics, Inc. | 12,720 | US$237K | 2.1% |
| Enliven Therapeutics, Inc. | 4,607 | US$234K | 2.0% |
| Amylyx Pharmaceuticals, Inc. | 12,663 | US$227K | 2.0% |
| Veradermics, Incorporated | 1,833 | US$225K | 2.0% |
| Ligand Pharmaceuticals Incorporated | 687 | US$217K | 1.9% |
| Nuvation Bio Inc. | 37,216 | US$211K | 1.8% |
| Edgewise Therapeutics, Inc. | 5,178 | US$210K | 1.8% |
| Nektar Therapeutics | 3,002 | US$210K | 1.8% |
| Liquidia Corporation | 2,612 | US$208K | 1.8% |
| Maze Therapeutics, Inc. | 6,930 | US$207K | 1.8% |
| Harrow, Inc. | 4,748 | US$202K | 1.8% |
| Eyepoint, Inc. | 13,824 | US$198K | 1.7% |
| Amneal Pharmaceuticals, Inc. | 11,126 | US$193K | 1.7% |
| Ocular Therapeutix, Inc. | 19,502 | US$192K | 1.7% |
| Corcept Therapeutics Incorporated | 2,182 | US$190K | 1.6% |
| Crinetics Pharmaceuticals, Inc. | 4,965 | US$186K | 1.6% |
| Pacira Biosciences, Inc. | 7,278 | US$185K | 1.6% |
| Merck & Company, Inc. | 1,431 | US$184K | 1.6% |
| Indivior Pharmaceuticals, Inc. | 4,475 | US$184K | 1.6% |
| Elanco Animal Health Incorporated | 7,453 | US$183K | 1.6% |
| Johnson & Johnson | 715 | US$182K | 1.6% |
| Eli Lilly And Company | 150 | US$180K | 1.6% |
| Jazz Pharmaceuticals Plc | 742 | US$179K | 1.6% |
| Collegium Pharmaceutical, Inc. | 4,898 | US$177K | 1.5% |
| Bristol-myers Squibb Company | 3,066 | US$177K | 1.5% |
| Supernus Pharmaceuticals, Inc. | 3,780 | US$176K | 1.5% |
| Royalty Pharma Plc | 3,127 | US$175K | 1.5% |
| Tarsus Pharmaceuticals, Inc. | 2,782 | US$175K | 1.5% |
| Wave Life Sciences Ltd. | 30,115 | US$175K | 1.5% |
| Harmony Biosciences Holdings, Inc. | 4,804 | US$175K | 1.5% |
| Ani Pharmaceuticals, Inc. | 2,084 | US$173K | 1.5% |
| Organon & Co. | 12,739 | US$172K | 1.5% |
| Viatris Inc. | 10,808 | US$172K | 1.5% |
| Esperion Therapeutics, Inc. | 54,283 | US$172K | 1.5% |
| Axsome Therapeutics, Inc. | 692 | US$169K | 1.5% |
| Innoviva, Inc. | 7,411 | US$168K | 1.5% |
| Bioage Labs, Inc. | 6,835 | US$168K | 1.5% |
| Prestige Consumer Healthcare Inc. | 3,469 | US$164K | 1.4% |
| Rapport Therapeutics, Inc. | 3,855 | US$161K | 1.4% |
| Pfizer, Inc. | 6,658 | US$160K | 1.4% |
| Omeros Corporation | 16,711 | US$159K | 1.4% |
| Perrigo Company Plc | 15,260 | US$159K | 1.4% |
| Xeris Biopharma Holdings, Inc. | 19,640 | US$156K | 1.4% |
| Zoetis Inc. | 2,097 | US$151K | 1.3% |
| Eton Pharmaceuticals, Inc. | 4,026 | US$146K | 1.3% |
| Phibro Animal Health Corporation | 4,568 | US$143K | 1.2% |
| Amphastar Pharmaceuticals, Inc. | 6,925 | US$140K | 1.2% |
| Arvinas, Inc. | 16,762 | US$139K | 1.2% |
| Zevra Therapeutics, Inc. | 9,630 | US$138K | 1.2% |
| Alto Neuroscience, Inc. | 4,959 | US$131K | 1.1% |
| Phathom Pharmaceuticals, Inc. | 10,944 | US$119K | 1.0% |
| Relmada Therapeutics, Inc. | 17,078 | US$118K | 1.0% |
| Cormedix Inc. | 14,334 | US$113K | 0.98% |
| Septerna, Inc. | 3,303 | US$111K | 0.96% |
| Theravance Biopharma, Inc. | 6,286 | US$107K | 0.93% |
| Aclaris Therapeutics, Inc. | 18,874 | US$99,843 | 0.87% |
| Lb Pharmaceuticals Inc | 2,742 | US$88,992 | 0.77% |
| Aquestive Therapeutics, Inc. | 20,535 | US$85,426 | 0.74% |
| Fulcrum Therapeutics, Inc. | 21,055 | US$77,061 | 0.67% |
| Lexicon Pharmaceuticals, Inc. | 29,252 | US$70,205 | 0.61% |
| Evolus, Inc. Common Stock | 8,464 | US$58,740 | 0.51% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |